| abstract |
It relates to bispecific antibody constructs of a specific Fc embodiment characterized by comprising a first domain that binds to BCMA, a second domain that binds to an extracellular epitope of the human and / or Macaque CD3epsilon chain, and a third domain, which is the specific modality Fc. Furthermore, the invention provides a polynucleotide, which encodes the antibody construct, a vector which comprises this polynucleotide, host cells, which express the construct, and a pharmaceutical composition which comprises the same. |